CCP
RMD icon

Cunning Capital Partners’s ResMed RMD Stock Holding History

Cunning Capital Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,930
Closed -$5.51M – 55
2020
Q4 		$5.51M Hold
25,930
– – 2.94% 18
2020
Q3 		$4.45M Hold
25,930
– – 2.81% 19
2020
Q2 		$4.98M Sell
25,930
-10,000
-28% -$1.64M 3.51% 13
2020
Q1 		$5.29M Buy
+35,930
New +$5.72M 4.89% 7

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cunning Capital Partners's RMD Position: Q1 2021 in Review

Cunning Capital Partners sold out of ResMed (RMD) in Q1 2021, closing a stake of 25,930 shares — an estimated $5.51M sold.

Cunning Capital Partners first reported a position in RMD in Q1 2020 and held it in 4 quarters. The position peaked at $5.51M in Q4 2020. 662 funds tracked by Wall St. Rank hold RMD as of Q1 2021.

  • Cunning Capital Partners reported no remaining ResMed position as of Q1 2021 after selling out during the quarter.
  • Cunning Capital Partners sold 25,930 ResMed shares in Q1 2021, an estimated $5.51M.
  • Cunning Capital Partners first reported a position in ResMed in Q1 2020 and held it in 4 quarters.
  • Cunning Capital Partners's ResMed position peaked at $5.51M in Q4 2020.
  • 662 funds tracked by Wall St. Rank held ResMed as of Q1 2021.

Based on Cunning Capital Partners's 13F filing for Q1 2021, filed 14 May 2021.